Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 1/2020

Open Access 01-01-2020 | Correction

Correction to: Longitudinal multi-modal muscle-based biomarker assessment in motor neuron disease

Authors: Thomas M. Jenkins, James J. P. Alix, Jacob Fingret, Taniya Esmail, Nigel Hoggard, Kathleen Baster, Christopher J. McDermott, Iain D. Wilkinson, Pamela J. Shaw

Published in: Journal of Neurology | Issue 1/2020

Login to get access

Excerpt

The original version of this article unfortunately contained a mistake. The numbers in the Table 5 appear to have been reproduced wrongly as dates, rather than percentages. …
Metadata
Title
Correction to: Longitudinal multi-modal muscle-based biomarker assessment in motor neuron disease
Authors
Thomas M. Jenkins
James J. P. Alix
Jacob Fingret
Taniya Esmail
Nigel Hoggard
Kathleen Baster
Christopher J. McDermott
Iain D. Wilkinson
Pamela J. Shaw
Publication date
01-01-2020
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 1/2020
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09648-8

Other articles of this Issue 1/2020

Journal of Neurology 1/2020 Go to the issue

Original Communication

Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis

Original Communication

Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS

Original Communication

No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab

Original Communication

Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson’s disease

Original Communication

European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A)

Original Communication

Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders